Delivery Order SPE2DB20D3101-SPE2DB24FRTT3
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The contract has a ceiling value of $3,266.90 and a period of performance through November 20, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $4,786.23 and a completion date of May 17, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,062.66 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges to support U.S. government medical requirements. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. There is no set-aside designation noted for this award. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a medication used to treat migraines. The contract has a firm fixed price of $10,321.41 and a period of performance extending through April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Imitrex 6 mg/0.5 ml cartridges, a prescription migraine medication. The total ceiling value of the contract is $13,412.57, and it has an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The fixed-price contract has a ceiling value of $3,501.16 and a period of performance through March 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The $3,639.24 firm fixed price contract has a performance period through January 21, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a prescription medication, with a ceiling value of $20,159.81 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $21,512.38 and runs through November 19, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,564,171,029 units of Imitrex 6 mg/0.5 ml cartridges. The delivery order contract has a firm fixed price of $12,332.63 and a period of performance through April 5, 2024. There is no set-aside designation associated with this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...